Tenaya therapeutics announces publication of tn-401 gene therapy preclinical data in nature communications medicine

Tn-401 aav9-based gene therapy being developed to treat the underlying cause of pkp2-associated arrhythmogenic right ventricular cardiomyopathy (arvc)

TNYA Ratings Summary

TNYA Quant Ranking